Compare Suncare Traders with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -7.87% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.12
- The company has been able to generate a Return on Equity (avg) of 1.86% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Risky - Negative EBITDA
Stock DNA
Trading & Distributors
INR 14 Cr (Micro Cap)
230.00
24
0.00%
0.14
4.43%
0.34
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Suncare Traders Ltd?
The next results date for Suncare Traders Ltd is scheduled for 07 May 2026....
Read full news article
Suncare Traders Ltd Falls to 52-Week Low of Rs 0.5 as Sell-Off Deepens
A sharp decline of 45.36% over the past year has culminated in Suncare Traders Ltd hitting a fresh 52-week low of Rs 0.5 on 22 Apr 2026, underscoring persistent weakness despite a broader market that has shown resilience in recent weeks.
Read full news article
Suncare Traders Ltd Falls to 52-Week Low of Rs 0.51 as Sell-Off Deepens
For the second consecutive session, Suncare Traders Ltd has succumbed to selling pressure, sliding to a fresh 52-week low of Rs 0.51 on 20 Apr 2026. This decline comes amid a broader market rally, highlighting a stark divergence between the stock and the benchmark indices.
Read full news article Announcements 
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.
28-Apr-2026 | Source : BSESuncare Traders Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 7th May 2026 inter alia to consider following businesses: - 1.) Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2026 along with the Reports of the Auditors thereon. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
22-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Suncare Traders Ltd |
| 2 | CIN NO. | L51909GJ1997PLC031561 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: COMPANY SECRETARY
EmailId: sctl31561@gmail.com
Designation: CFO
EmailId: sctl31561@gmail.com
Date: 22/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSEPFA
Corporate Actions 
07 May 2026
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.29%)
Shah Enterjrise (11.76%)
65.32%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -63.16% vs 480.00% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -100.00% vs -99.34% in Mar 2024
YoY Growth in year ended Mar 2025 is 51.28% vs 102.11% in Mar 2024






